NextCure to Present at the 20th Annual Needham Virtual Healthcare Conference
April 07, 2021 16:05 ET
|
NextCure
BELTSVILLE, Md., April 07, 2021 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class...
NextCure Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
March 04, 2021 16:05 ET
|
NextCure
BELTSVILLE, Md., March 04, 2021 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class...
REMINDER: NextCure to Host Virtual R&D Update Event on March 4, 2021
March 02, 2021 16:05 ET
|
NextCure
BELTSVILLE, Md., March 02, 2021 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class...
NextCure to Host Virtual R&D Update Event on March 4, 2021
February 26, 2021 16:15 ET
|
NextCure
BELTSVILLE, Md., Feb. 26, 2021 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class...
Dr. Han Myint Appointed as NextCure’s Chief Medical Officer
January 14, 2021 16:05 ET
|
NextCure
BELTSVILLE, Md., Jan. 14, 2021 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class...
NextCure Provides Updates on NC318 Clinical Program
December 17, 2020 07:05 ET
|
NextCure
BELTSVILLE, Md., Dec. 17, 2020 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class...
NextCure to Present at Piper Sandler Virtual 32nd Annual Healthcare Conference
November 23, 2020 16:05 ET
|
NextCure
BELTSVILLE, Md., Nov. 23, 2020 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class...
NextCure Reports Third Quarter 2020 Financial Results
November 05, 2020 16:27 ET
|
NextCure
BELTSVILLE, Md., Nov. 05, 2020 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class...
NextCure Announces Appointment of John G. Houston, Ph.D., to its Board of Directors
September 14, 2020 16:05 ET
|
NextCure
BELTSVILLE, Md., Sept. 14, 2020 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class...
NextCure to Present at Morgan Stanley Virtual 18th Annual Global Healthcare Conference
September 08, 2020 08:05 ET
|
NextCure
BELTSVILLE, Md., Sept. 08, 2020 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class...